Concurrent Investment Advisors, LLC Humacyte, Inc. Transaction History
Concurrent Investment Advisors, LLC
- $5.17 Trillion
- Q2 2025
A detailed history of Concurrent Investment Advisors, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 51,115 shares of HUMA stock, worth $118,075. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,115
Previous 43,500
17.51%
Holding current value
$118,075
Previous $74.2 Million
44.04%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HUMA
# of Institutions
186Shares Held
60.2MCall Options Held
1.21MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$15.2 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$9.85 Million0.0% of portfolio
-
Heights Capital Management, Inc San Francisco, CA4.03MShares$9.3 Million3.22% of portfolio
-
Woodline Partners LP San Francisco, CA3.95MShares$9.12 Million0.05% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $238M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...